Clinical Trials
Results of Subpopulation Analysis of Patients with Hepatitis B...
Eisai Co., Ltd. has announced that the results of a subpopulation analysis of patients with hepatitis B virus (HBV) coinfection in a Phase III trial...
Clinical Trials
Clinical studies with a new compound –PM14- in patients...
With the motivation of finding a solution to the unmet needs of patients with different types of cancer, PharmaMar (MSE:PHM) announces the start of a...
Clinical Trials
Levicept Starts First-in-Human Phase I Trial of LEVI-04, A...
Levicept Ltd., an asset-centric biotechnology company focused on the development of LEVI-04, a first-in-class treatment for chronic pain indications announces that it has commenced its...
Clinical Trials
Successful Industrial GMP Manufacturing of RIBOXXIM, a Novel and...
RIBOXX PHARMACEUTICALS, a biotech company developing Toll-like-receptor (TLR) and RIG-I-like-Receptor (RLR) ligands, and ACCINOV, a pharmaceutical establishment for experimental drug product announced the successful industrial...
Clinical Trials
Positive Dupilumab Topline Results From Phase 3 Trial In...
Regeneron Pharmaceuticals, Inc. and Sanofi announced that the pivotal Phase 3 LIBERTY ASTHMA QUEST study of dupilumab in a broad population of patients with uncontrolled,...
Clinical Trials
Presented in VIVA Late Breaking Clinical Trials Medtronic IN.PACT...
Medtronic plc data announced reinforce the durability and safety of the IN.PACT(TM) Admiral(TM) drug-coated balloon (DCB) in patients with peripheral arterial disease (PAD). ...
Clinical Trials
License Expansion for RGN-137 in Europe, S. Korea, Japan,...
RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration announced that it has...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.